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IMPACT OF COMMUNITY-ACQUIRED 
PNEUMONIA TREATMENT GUIDELINES ON 
LENGTH OF STAY AND COST
Merchant SV, Mullins CD, Cooke CE
Pharmacy Practice and Science, University of Maryland, School 
of Pharmacy, Baltimore, MD, USA
Community-acquired pneumonia (CAP) is associated
with significant morbidity, mortality and utilization of
health care resources. Strategies for decreasing cost of
treating CAP include identifying low-risk patients and
promoting the use of appropriate antibiotic therapy. Three
MCOs in the Greater Baltimore Washington DC area uti-
lized a prediction rule for triaging patients with CAP
(outpatient, inpatient or ICU), based on the risk for mor-
tality, and jointly developed a treatment guideline based
on the triaging. The guidelines were distributed to physi-
cians within the three plans. OBJECTIVE: To determine
the impact of the CAP treatment guidelines on LOS and
cost. METHODS: Health and demographic information
were abstracted from medical chart review and merged
with billing data from these insurance plans for randomly
selected patients. LOS and costs were compared for the
two periods: pre-intervention and post-intervention. RE-
SULTS: A decrease in LOS was observed in the post-inter-
vention period for all the three plans by 0.5 days (P 
0.69), 0.6 days (P  0.43), and 0.4 days (P  0.01) re-
spectively. There was a decrease in the mean amounts
billed for the three plans. The decrease in the mean
amounts billed was $2,257 (P  0.01), $1,801 (P 
0.77), and $259 (P  0.13) respectively. Results suggest
that there may have been a favorable impact on both the
LOS and cost across the three plans, but the results were
not statistically significant. The guidelines had no impact
on readmission or mortality. CONCLUSION: A reduc-
tion in LOS and cost was observed in all the three plans.
Treatment guidelines provide a useful tool to reduce vari-
ability in rates of hospitalization and aid physicians in
making proper decisions regarding treatment.
S2
USE OF ESTROGEN REPLACEMENT THERAPY IN 
MARYLAND MEDICAID FEMALES
Huang X, Weiss SR, Zuckerman IH, Hsu VD
School of Pharmacy, University of Maryland, Baltimore, MD, 
USA
OBJECTIVES: To describe use of estrogen replacement
therapy (ERT) among Maryland Medicaid females and
to identify factors associated with its use and discontinu-
ation. METHODS: This study was conducted using
Medicaid claims data to identify women, age 45 years or
older, with at least two years of continuous Medicaid eli-
gibility between October 1, 1995 and September 30,
1998. Drug use was based on prescription claims and
clinical characteristics were based on medical, institu-
tional, and prescription claims. RESULTS: 60,531 female
recipients were eligible for the study with a mean age of
68 years (SD  12.9). The overall ERT prevalence was
14%. ERT use was the highest in the 45–54 age group
(23.9%, P  0.001) and higher among white than non-
white women (15.7% vs. 12.9%, P  0.001). Unop-
posed estrogen products were dispensed to 70.5% of
ERT users (average duration  142 days). The remainder
used estrogen-progestin combinations and had shorter
duration (average  85 days). ERT use was higher among
women with osteoporosis, ischemic heart disease, hyper-
tension, hyperlipidemia, or diabetes as compared to pa-
tients without these conditions (P  0.001). ERT use was
low among breast cancer patients (P  0.001), whereas a
diagnosis of endometrial cancer, or thromboembolic dis-
ease was unrelated to ERT use. Using proportional haz-
ards models, discontinuation of ERT was associated with
nonwhite race (P  0.001) and estrogen sensitive cancers
(P  0.001). Conversely, having claims indicative of os-
teoporosis, ischemic heart disease, hypertension, or hy-
perlipidemia was unrelated to discontinuation of ERT.
CONCLUSION: ERT use in this population was low
compared to estimates for US women 50 or older based
on NHANES III. Intervention should be considered to in-
crease ERT use among women with cardiac risk factors
and to improve long-term compliance. 
S3
STATISTICAL METHOD FOR MODELING DUAL 
SELECTION BIAS: WOODWORK EFFECT AND 
DRUG SELECTION BIAS AMONG 
MULTIPLE ALTERNATIVES
Shi L, McCombs JS
Department of Pharmaceutical Economics and Policy, School 
of Pharmacy, University of Southern California, Los Angeles, 
CA, USA
BACKGROUND: The California Medicaid program
(Medi-Cal) added fluoxetine and paroxetine to its formu-
lary in May 1996. This policy change created two types
of selection bias that must be accounted for in compari-
sons across drugs. First, new patients may have sought
treatment in response to the change (woodwork effect).
Second, prescribing patterns may have also changed
(drug selection bias). OBJECTIVES: This study used a
Dual- method to adjust jointly for these two selectivity
biases in evaluating the effects of alternative antidepres-
sant therapies on health care costs. METHODS: All pa-
tients with a recorded diagnosis of major depression
(MDD) between 04/01/1994 and 01/31/1999 were se-
lected from the Medi-Cal paid claims system. Results
from the Dual- method were compared with the stan-
dard Heckman-Lee method. RESULTS: The formulary
policy change was a statistically significant factor in the
woodwork effect and altered antidepressant selection
patterns. In the second-stage cost models with double s,
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the biases associated with the woodwork effect were statis-
tically significant (fluoxetine P  0.0055, paroxetine P 
0.0041, and sertraline P  0.3261). None of antidepres-
sant selection biases were significant. No statistical signif-
icance differences were found in total health care costs
for patients initiating therapies with these three SSRIs as
compared with TCAs. However, in models with a single
 to adjust only for treatment selection bias, the fluoxet-
ine group had significant drug selection bias (P 
0.0418) and significant high total health care cost as
compared with TCAs (P  0.0076). CONCLUSION:
Double- method better resolved the selection biases in
antidepressant therapy in an evaluation of the impact of
alternative therapies on post-treatment costs following a
formulary change than the Heckman-Lee method.
S4
METHODS FOR COMPARING AREAS UNDER 
RECEIVER OPERATING CHARACTERISTIC 
CURVES: APPLICATION IN SCREENING 
ACCURACY FOR DEPRESSION
Shaw JW1, Treglia M1, Motheral B2, Coons SJ2
1Global Health Outcomes Research, Eli Lilly and Company, 
Indianapolis, IN, USA; 2College of Pharmacy, The University of 
Arizona, Tucson, AZ, USA
Receiver operating characteristic (ROC) analysis is often
used to assess the screening accuracy of continuous mea-
sures. Hanley and McNeil (Radiology 1983;148:839–
843) developed a method for comparing ROC curves
that is widely used in the literature. DeLong et al. (Bio-
metrics 1988;44:837–845) subsequently developed an
improved method; however, it has not become popular
due to its perceived complexity. OBJECTIVE: This re-
search compared the method of DeLong et al. to that of
Hanley and McNeil. METHODS: The data were drawn
from a sample of over 1,215 primary care patients partic-
ipating in the Longitudinal Investigation of Depression
Outcomes (LIDO) study. Three continuous measures (i.e.,
CES-D, MHI-5, and MCS-12) were compared in terms of
their ability to detect diagnosis of major depression based
on the CIDI. Values for area under the ROC curve (AUC)
were computed for the three measures and compared sta-
tistically using the DeLong et al. and Hanley and McNeil
methods. RESULTS: The two methods yielded entirely
different statistical conclusions. Using the DeLong et al
method, z statistics for difference between AUC values
were 15–22% larger. The DeLong et al method yielded
confidence intervals that were 17–25% narrower than
those derived using the method of Hanley and McNeil.
The statistical efficiency of the Hanley and McNeil
method relative to that of DeLong et al ranged from 64–
73%. CONCLUSIONS: The DeLong et al method is
more elegant and precise than that developed by Hanley
and McNeil. The results of this investigation indicate that
the former would require fewer patients than the latter to
achieve a fixed level of statistical power.
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POSTOPERATIVE PAIN SEVERITY AFTER 
ABDOMINAL OR ORTHOPEDIC SURGERY: 
INTERIM RESULTS
Strassels S1, Chen C2, Carr D1, McDonagh M1, Gouveia W1, 
Wurm H1
1New England Medical Center, Boston, MA, USA; 2Searle 
Pharmaceuticals, Skokie, IL, USA
For many people, postoperative pain is suboptimally con-
trolled, however, limited information is available about
pain from the patient’s perspective. OBJECTIVES: A
purpose of this pilot study was to describe patient’s post-
operative pain after abdominal or orthopedic surgery.
METHODS: Seventeen persons who underwent total ab-
dominal hysterectomy (TAH), or total hip or knee re-
placement (THR, TKR) between August and November
1999 completed a modified version of the American Pain
Society (APS) Quality Improvement questionnaire within
24 hours before leaving the hospital. Pain was rated on a
0 (no pain) – 10 (worst pain possible) analog scale. RE-
SULTS: Mean age was 43.7 years for TAH (n  7), 55.0
years for THR (n  4), and 61.8 years for TKR patients
(n  6). Mean length of stay (days) was 3.6 overall, 3.2
for TAH, 3.8 for THR, and 4.2 for TKR. All patients had
pain within 24 hours before leaving the hospital. At the
time patients completed the survey, mean pain levels
were 4.1, 3.2, and 2.2 for persons after TAH, THR, and
TKR, respectively. Mean worst pain was 9.1, 7.8, and
8.0 for TAH, THR, and TKR patients, respectively. Pain
was most severe on the first or second day after surgery
for 86.7%, 75.0%, and 100% of TAH, THR, and TKR
patients, respectively. CONCLUSIONS: Postoperative
pain was most severe on the first and second days after
surgery for most patients. Postoperative pain levels at dis-
charge suggest that patients will require additional anal-
gesia at home.
BT2
DIRECT COSTS OF OBESITY IN PORTUGAL
Pereira J1, Mateus C2, Amaral, MJ2
1National School of Public Health, New University, Lisbon, 
Portugal; 2Ministry of Health, Lisbon, Portugal
In Portugal (population 10 million), 12% of the adult
population is obese (BMI 30) and almost 50% are
overweight (BMI 25). These persons have an increased
risk of morbidity and premature death due to various dis-
eases (e.g. type II diabetes, hypertension, coronary heart
disease and some forms of cancer). OBJECTIVES: To
calculate the direct economic cost of illness associated
with obesity in Portugal. METHODS: A prevalence-
based COI approach is adopted. Data are drawn from
the National Health Survey, the hospital information sys-
